Endocrinology
Type 2 diabetes management in China
Comprehensive T2DM care at Class A endocrinology departments — GLP-1, SGLT2 inhibitors, modern insulins, structured education, and integration with cardiometabolic and renal screening.
Overview
Type 2 diabetes affects approximately 140 million adults in China alone — one of the highest national totals globally. Class A endocrinology departments at academic centres run integrated programmes that combine GLP-1 receptor agonists, SGLT2 inhibitors, modern insulins, and structured cardiometabolic / renal monitoring at substantially lower cost than US/EU equivalents.
Modern T2DM care has moved beyond glycaemic control alone — the priority is reducing cardiovascular and renal risk, and many GLP-1 / SGLT2 agents have proven outcomes data for those endpoints.
Common symptoms
- Often asymptomatic in early stages — many cases diagnosed incidentally on routine screening
- Polyuria, polydipsia, blurred vision, recurrent infections in established disease
- Fatigue, weight changes, slow wound healing
- Numbness or tingling in hands / feet (neuropathy in long-standing disease)
Risk factors
- BMI ≥ 25 (or ≥ 23 in Asian populations)
- Family history of T2DM
- Sedentary lifestyle
- History of gestational diabetes
- Hypertension, dyslipidaemia, PCOS
- Age over 45
Standard diagnostic workup
Cost band at Class A international department: USD 140–220 all-in.
- Fasting glucose + HbA1c
- Oral glucose tolerance test (OGTT) when HbA1c is borderline
- Lipid panel, ALT/AST, eGFR, urine albumin/creatinine ratio
- Comprehensive cardiovascular risk assessment
- Diabetic eye examination at diagnosis (retinal screen)
- Foot examination and neuropathy screening
Treatment options
Metformin
First-line for most patients without contraindication. Generic, very inexpensive.
GLP-1 receptor agonists (semaglutide, tirzepatide, dulaglutide)
Strong glycaemic and weight benefits, cardiovascular outcome benefits in dedicated trials. China price 60–80% below US private pay.
SGLT2 inhibitors (empagliflozin, dapagliflozin)
Cardiorenal protection in addition to glycaemic effect. Particularly relevant for patients with CKD or heart failure.
Structured education + lifestyle programme
Foundational. Available as group programmes at Class A centres.
DPP-4 inhibitors
Weight-neutral, well-tolerated. Modest A1c effect.
Modern basal / basal-bolus insulin
Insulin glargine, degludec, lispro, aspart — all available at substantially lower cost.
Frequently asked
- What's my 10-year risk of developing diabetes?
- Take our FINDRISC self-test for a validated 8-item risk score recognised by the International Diabetes Federation.
- What does T2DM workup cost in China?
- Endocrinology consult + comprehensive metabolic + lipid + renal panel + initial foot/eye screening: USD 140–220 at a Class A international department, vs USD 600–1,200 US private.
- Are modern insulins cheaper in China?
- Yes. Insulin glargine biosimilars are USD 15–30 per vial vs USD 100+ US private pay. Modern rapid-acting analogues (lispro, aspart) similarly priced. Insulin pump and CGM access is available with appropriate prescribing.
- What about diabetes remission with bariatric surgery?
- Bariatric surgery (especially RYGB and SADI) drives durable T2DM remission in 65–80% of eligible patients with BMI ≥ 35. See bariatric procedures.
Type 2 diabetes 10-year risk (FINDRISC)
Finnish Diabetes Risk Score — validated 8-item tool predicting 10-year risk of developing type 2 diabetes.
Take the Diabetes risk screenerRelated medication
Medication detail →Related specialty
Endocrinology hub →Further reading
GLP-1 in China: Real Costs, Real Workups, and What's Actually Better Than the US
Semaglutide and tirzepatide are revolutionising weight loss globally — but the price gap between US and Chinese hospital pharmacies is enormous. Here is what you actually get for the difference.
EndocrinologyWhat $400 Buys at a Class A Endocrinology Department in China
A line-by-line breakdown of what a typical pre-treatment endocrinology workup at a Class A international department actually includes — and why this matters for GLP-1, thyroid, and metabolic patients.
Talk to a senior physician
Free 30-minute video consult to review your case. We'll quote a workup and treatment plan at a Class A partner hospital — no commitment.
Book free consult